We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

Application Note
IsoPlexis Proteomic Product Suite for NK Cells

Learn how IsoPlexis’ functional proteomics reveals unique secretomic signatures and insights into NK Cells.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Application Note we discuss:

Predictive durability biomarkers with a combination PEG-IL2 and checkpoint therapy
Clinical immune monitoring with immune checkpoint inhibitor therapies
Early indicators of patient response and relapse with immune checkpoint inhibitor therapies
Identifying therapeutic targets driving COVID inflammation
Mechanisms of immune persistence in solid tumor indications
Early indicators of potency in a combination immune checkpoint and TIL Therapy, and much more!
A Deeper Look

More about this Application Note

Overcoming Challenges in NK Cell Research

Immune monitoring is critical in therapeutic development to understand how cellular functional phenotype influences therapeutic efficacy and disease progression. However, challenges such as limited persistence and tumor evasion test the durability and efficacy of these novel therapies.

Download this App Note to learn how IsoPlexis researchers better understand the functional mechanisms of NK cell potency and persistence.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the Application Note
Back to the Top